Ryan Nicholson Sells 1,183 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) CAO Ryan Nicholson sold 1,183 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total value of $77,226.24. Following the completion of the transaction, the chief accounting officer owned 34,453 shares in the company, valued at approximately $2,249,091.84. This trade represents a 3.32% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Ryan Nicholson also recently made the following trade(s):

• On Monday, August 10th, Ryan Nicholson sold 1,348 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.04, for a total transaction of $83,629.92.
• On Tuesday, August 4th, Ryan Nicholson sold 357 shares of Dolby Laboratories stock. The stock was sold at an average price of $60.63, for a total transaction of $21,644.91.

Dolby Laboratories Trading Down 1.4%

Shares of NYSE DLB opened at $61.51 on Friday. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $73.78. The stock has a market cap of $5.76 billion, a PE ratio of 26.17 and a beta of 0.80. The company has a 50-day moving average of $55.67 and a 200 day moving average of $58.52.

Dolby Laboratories (NYSE:DLB) last issued its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The business had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The company’s revenue for the quarter was down 3.3% on a year-over-year basis. During the same period last year, the company earned $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. On average, sell-side analysts forecast that Dolby Laboratories will post 3.23 EPS for the current fiscal year.

Dolby Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.3%. Dolby Laboratories’s dividend payout ratio is currently 61.28%.

Dolby Laboratories announced that its Board of Directors has initiated a stock repurchase plan on Thursday, July 30th that authorizes the company to repurchase $350.00 million in outstanding shares. This repurchase authorization authorizes the electronics maker to repurchase up to 7% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

Key Headlines Impacting Dolby Laboratories

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Buy rating reaffirmed: Rosenblatt Securities maintained its “buy” rating and set an $85 price target, implying substantial upside from recent trading levels. The call may support the shares by signaling confidence in Dolby’s valuation and longer-term earnings potential. Benzinga analyst rating article
• Positive Sentiment: Expansion into new markets: Dolby is pursuing opportunities in in-car gaming and live sports streaming, potentially broadening its licensing base beyond traditional cinema, television and streaming applications. These initiatives could provide additional long-term growth drivers. Dolby expands into in-car gaming and live sports streaming
• Neutral Sentiment: CEO succession announced: Kevin Yeaman will retire after nearly two decades with Dolby, while Marc Whitten becomes president, CEO and a board member. The planned succession may provide continuity, but investors will assess whether the new leadership can accelerate growth while preserving Dolby’s licensing model. Dolby Laboratories leadership transition announcement
• Neutral Sentiment: Earnings outlook remains mixed: Zacks Research raised several estimates for early 2027 and 2028 quarters, but reduced forecasts for fourth-quarter 2026, third-quarter and fourth-quarter 2027, FY2027 and FY2028. The revisions suggest pockets of strength but limited confidence in consistent growth. Zacks Research earnings outlook
• Negative Sentiment: Chief accounting officer sold shares: CAO Ryan Nicholson sold 1,183 shares for approximately $77,226, reducing his direct holdings by 3.32%. The sale is relatively small and may reflect personal financial planning, but it adds to recent insider selling and can weigh on sentiment. Dolby Laboratories insider stock sale

Analyst Upgrades and Downgrades

Several research analysts recently commented on DLB shares. Rosenblatt Securities reissued a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a research note on Friday. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, June 15th. Finally, Weiss Ratings downgraded Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, August 13th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Dolby Laboratories currently has an average rating of “Hold” and an average price target of $83.00.

Hedge Funds Weigh In On Dolby Laboratories

A number of institutional investors and hedge funds have recently modified their holdings of DLB. Corient Private Wealth LP purchased a new stake in Dolby Laboratories during the 2nd quarter worth about $234,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Dolby Laboratories during the 2nd quarter worth about $216,000. California State Teachers Retirement System lifted its stake in Dolby Laboratories by 5,009.3% during the second quarter. California State Teachers Retirement System now owns 3,705,155 shares of the electronics maker’s stock worth $194,817,000 after purchasing an additional 3,632,637 shares during the last quarter. Ameritas Advisory Services LLC lifted its stake in Dolby Laboratories by 46.6% during the second quarter. Ameritas Advisory Services LLC now owns 5,701 shares of the electronics maker’s stock worth $300,000 after purchasing an additional 1,813 shares during the last quarter. Finally, AlphaGrep UK Ltd acquired a new position in Dolby Laboratories in the second quarter valued at approximately $649,000. Institutional investors and hedge funds own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.